Mobile Menu

Video Category

← All Categories

How Genomics is Changing the Shape of Healthcare: England’s NHS Continues its Momentum
How Genomics is Changing the Shape of Healthcare: England’s NHS Continues its Momentum
Dame Sue Hill, Chief Scientific Officer, NHS England and NHS Improvement
Spatial and temporal RNA-sequencing
Spatial and temporal RNA-sequencing
Sam Rodriques, Group Leader, Francis Crick Institute
All of Us Research Program: Advancing Precision Health for All Populations
All of Us Research Program: Advancing Precision Health for All Populations
Stephanie Devaney, Chief Operating Officer, All of Us Research Programme,National Institutes of Health (NIH)
Cancer evolution, immune evasion and metastasis
Cancer evolution, immune evasion and metastasis
Charles Swanton, Senior Group Leader, Crick Institute
The Forefront of Genomics: Opportunities, Challenges, and Imperatives
The Forefront of Genomics: Opportunities, Challenges, and Imperatives
Eric Green, Director, National Human Genome Research Institute (NHGRI)
Combining long and short read sequencing
Combining long and short read sequencing
Andrew Beggs, Mike Hubank and Matt Loose
Molecular diagnostics and the NHSE Long Term Plan for Cancer
Molecular diagnostics and the NHSE Long Term Plan for Cancer
Peter Johnson, National Clinical Director for Cancer, NHS England
Data Science as a Catalyst for Change: Lessons Learned from the Pandemic and Beyond
Data Science as a Catalyst for Change: Lessons Learned from the Pandemic and Beyond
Andrew Morris, Director, HDRUK
Translating germline cancer genomics into precision prevention of cancer
Translating germline cancer genomics into precision prevention of cancer
Clare Turnbull, Professor of Translational Cancer Genetics, Institute of Cancer Research
Rare Disease as an Emerging Field of Medicine
Rare Disease as an Emerging Field of Medicine
Marshall Summar, Director, Rare Disease Institute, Children’s National Health System
Applications of RNA-seq for infectious disease research
Applications of RNA-seq for infectious disease research
Jose Afonso Guerra-Assuncao, Research Associate, UCL
UK Biobank: Going Beyond Genomics in 2022
UK Biobank: Going Beyond Genomics in 2022
Mark Effingham, Deputy Chief Executive Officer, UK Biobank
Drugging the cancer genome: progress, opportunities and challenges in personalised medicine
Drugging the cancer genome: progress, opportunities and challenges in personalised medicine
Paul Workman, Professor of Pharmacology and Therapeutics, Institute of Cancer Research
Advancing Genomic Medicine Through Global Collaboration and Data Sharing
Advancing Genomic Medicine Through Global Collaboration and Data Sharing
Heidi Rehm, Chief Genomics Officer, Centre for Genomic Medicine and Co-Director, Medical and Population Genetics, Massachesetts General Hospital and Broad Institute
The Future of Genomics: Health and Beyond
The Future of Genomics: Health and Beyond
Sir Patrick Vallance, Government Chief Scientific Adviser, UK Government
Bringing the Benefits of Genomics to Everyone – Genomics England’s Efforts in 2022 and Beyond
Bringing the Benefits of Genomics to Everyone – Genomics England’s Efforts in 2022 and Beyond
Chris Wigley, Chief Executive Officer, Genomics England
Liquid biopsy: From discovery to clinical implementation
Liquid biopsy: From discovery to clinical implementation
Klaus Pantel, Chairman of the Institute of Tumour Biology, University Centre Hamburg-Eppendorf
Mapping immune cells in tissues using single cell and spatial genomics
Mapping immune cells in tissues using single cell and spatial genomics
Sarah Teichmann, Cellular Genetics Programme Head, Wellcome Sanger Institute
Genomics for better health
Genomics for better health
Featuring speakers from GSK and the University of Oxford

Sub Categories

Week 1
Week 1
5 videos
Week 2
Week 2
4 videos
Week 3
Week 3
1 video
Week 4
Week 4
5 videos
Week 5
Week 5
3 videos
Week 6
Week 6
1 video